Extrinsic allergic alveolitis.
Extrinsic allergic alveolitis is caused by the inhalation of small organic allergen particles by non-atopic subjects which provoke an allergic reaction, thought to be chiefly due to a type III mechanism, in the peripheral respiratory tissues. The clinical features are determined by the nature of exposure, the immunopathological mechanism(s) involved and the site of reaction in the lung. When the exposure is intermittent and intensive, febrile episodes with respiratory symptoms beginning after four to six hours are prominent, but when it is more continuous and less intensive they are not and the features are those of a chronic fibrosing lung disease. The diagnosis is important to make because management by the avoidance of exposure is followed by improvement. It is made by recognizing the clinical presentation, by identifying the source of allergen exposure and by obtaining supportive evidence from precipitin and skin tests, or from allergen inhalation tests or lung biopsy.
D000485:Allergens; D000906:Antibodies / Q000032:analysis; D000937:Antigen-Antibody Reactions; D001706:Biopsy; D003937:Diagnosis, Differential; D004781:Environmental Exposure; D006801:Humans; D008168:Lung / Q000473:pathology; D008487:Medical History Taking; D010316:Particle Size; D011009:Pneumoconiosis; D011241:Prednisone / Q000627:therapeutic use; D011650:Pulmonary Alveoli / Q000473:pathology; D011859:Radiography; D012129:Respiratory Function Tests; D012130:Respiratory Hypersensitivity / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D012140:Respiratory Tract Diseases / Q000175:diagnosis; D012882:Skin Tests
D000485:Allergens; D000906:Antibodies; D011241:Prednisone